Alondra Renn
In the quest for novel pharmacological agents with diverse therapeutic applications, the exploration of heterocyclic compounds remains pivotal. Among these, the class of 5-Arylidene(chromenyl-methylene)-thiazolidinediones has emerged as a promising avenue, showcasing intriguing synthesis methodologies, structural diversity and notable biological activities. This article delves into the synthesis strategies, structural elucidation and the multifaceted biological potentials of these compounds, shedding light on their significance in contemporary drug discovery endeavors.
Partagez cet article
English 
Spanish 
Chinese 
Russian 
German 
Japanese 
Portuguese 
Hindi 